A recent study showed that miR-497 negatively regulated glioma cells by targeting oncogene Wnt3α and that reduced expression of miR-497 was associated with poor disease-free and overall survival rates (Lu et al., 2018). The gene discussed is WNT3A; the disease is glioma.